Glycogen storage disease type I CT: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Abdominal computed tomography or magnetic resonance imaging with contrast is performed to screen for hepatocellular carcinoma and should be repeated every 6 - 12 months or earlier on the basis of laboratory and clinical findings. | Abdominal [[computed tomography]] or [[magnetic resonance imaging]] with contrast is performed to screen for [[hepatocellular carcinoma]] and should be repeated every 6 - 12 months or earlier on the basis of [[laboratory]] and clinical findings. | ||
==CT== | ==CT== | ||
*Abdominal computed tomography or magnetic resonance imaging with contrast is performed to screen for hepatocellular carcinoma in patients including:<ref name="KishnaniAustin2014">{{cite journal|last1=Kishnani|first1=Priya S.|last2=Austin|first2=Stephanie L.|last3=Abdenur|first3=Jose E.|last4=Arn|first4=Pamela|last5=Bali|first5=Deeksha S.|last6=Boney|first6=Anne|last7=Chung|first7=Wendy K.|last8=Dagli|first8=Aditi I.|last9=Dale|first9=David|last10=Koeberl|first10=Dwight|last11=Somers|first11=Michael J.|last12=Burns Wechsler|first12=Stephanie|last13=Weinstein|first13=David A.|last14=Wolfsdorf|first14=Joseph I.|last15=Watson|first15=Michael S.|title=Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics|journal=Genetics in Medicine|year=2014|issn=1098-3600|doi=10.1038/gim.2014.128}}</ref> | *Abdominal [[computed tomography]] or [[magnetic resonance imaging]] with contrast is performed to screen for [[hepatocellular carcinoma]] in patients including:<ref name="KishnaniAustin2014">{{cite journal|last1=Kishnani|first1=Priya S.|last2=Austin|first2=Stephanie L.|last3=Abdenur|first3=Jose E.|last4=Arn|first4=Pamela|last5=Bali|first5=Deeksha S.|last6=Boney|first6=Anne|last7=Chung|first7=Wendy K.|last8=Dagli|first8=Aditi I.|last9=Dale|first9=David|last10=Koeberl|first10=Dwight|last11=Somers|first11=Michael J.|last12=Burns Wechsler|first12=Stephanie|last13=Weinstein|first13=David A.|last14=Wolfsdorf|first14=Joseph I.|last15=Watson|first15=Michael S.|title=Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics|journal=Genetics in Medicine|year=2014|issn=1098-3600|doi=10.1038/gim.2014.128}}</ref> | ||
**Pediatric age group once adenoma is detected on ultrasound | **Pediatric age group once [[adenoma]] is detected on [[ultrasound]] | ||
**Older patients even if there is no adenoma on ultrasound | **Older patients even if there is no [[adenoma]] on [[ultrasound]] | ||
*These investigations should be repeated every 6 - 12 months or earlier on the basis of laboratory and clinical findings. | *These investigations should be repeated every 6 - 12 months or earlier on the basis of [[laboratory]] and clinical findings. | ||
==References== | ==References== | ||
Revision as of 15:44, 21 November 2017
|
Glycogen storage disease type I Microchapters |
|
Differentiating Glycogen storage disease type I from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type I CT On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type I CT |
|
Directions to Hospitals Treating Glycogen storage disease type I |
|
Risk calculators and risk factors for Glycogen storage disease type I CT |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Abdominal computed tomography or magnetic resonance imaging with contrast is performed to screen for hepatocellular carcinoma and should be repeated every 6 - 12 months or earlier on the basis of laboratory and clinical findings.
CT
- Abdominal computed tomography or magnetic resonance imaging with contrast is performed to screen for hepatocellular carcinoma in patients including:[1]
- Pediatric age group once adenoma is detected on ultrasound
- Older patients even if there is no adenoma on ultrasound
- These investigations should be repeated every 6 - 12 months or earlier on the basis of laboratory and clinical findings.
References
- ↑ Kishnani, Priya S.; Austin, Stephanie L.; Abdenur, Jose E.; Arn, Pamela; Bali, Deeksha S.; Boney, Anne; Chung, Wendy K.; Dagli, Aditi I.; Dale, David; Koeberl, Dwight; Somers, Michael J.; Burns Wechsler, Stephanie; Weinstein, David A.; Wolfsdorf, Joseph I.; Watson, Michael S. (2014). "Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics". Genetics in Medicine. doi:10.1038/gim.2014.128. ISSN 1098-3600.